Peer-reviewed veterinary case report
Surgical treatment outcomes for cats with blocked ureters
By Shigihara, Kae et al.·Published in Journal of feline medicine and surgery·2026·Carlson College of Veterinary Medicine, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Benign ureteral obstruction in cats treated surgically: a retrospective review of 105 cats.
- Species:
- cat
Plain-English summary
A group of 105 cats with benign ureteral obstruction (a blockage in the tube that carries urine from the kidney) underwent surgery to relieve their condition. The cats were treated with three different surgical methods: ureteral stenting, subcutaneous ureteral bypass, or ureterotomy. The ureterotomy method had the best outcomes, with fewer complications and better long-term health improvements. Most cats recovered well, with a median survival time of over four years for those treated with ureterotomy.
People also search for: cat ureteral obstruction surgery · cat urinary blockage treatment · cat surgery recovery time
Abstract
ObjectivesThe aim of the present study was to report the postoperative short- and long-term outcomes in cats with benign ureteral obstruction treated surgically with ureteral stent, subcutaneous ureteral bypass (SUB) or ureterotomy.MethodsSignalment, surgery time, hospitalization duration, pre- and postoperative biological and biochemical parameters, postoperative revision surgery rate, and date of death or last follow-up date were recorded. Pre- and postoperative biological and biochemical parameters, risk of major complications requiring revision surgery and survival time were statistically analyzed.ResultsA total of 105 cats (128 ureters) met the inclusion criteria, consisting of 34 ureters in the stent group, 43 in the SUB group and 51 in the ureterotomy group. There was no significant difference in sex, body weight (BW), serum creatinine, potassium, phosphorus, pH, base excess or packed cell volume (PCV) preoperatively between the three surgical groups. Surgery time and hospitalization duration were significantly longer in the stent group compared with the other two groups. Major complications requiring revision surgeries were 41%, 23%, 15% in the stent, SUB and ureterotomy groups, respectively. The median survival time (MST) was 1426 days in the stent group; MST was not reached in the SUB or ureterotomy groups during the study. Five cats (4.4%; one stent, three SUBs, one ureterotomy) died within 10 days postoperatively. The ureterotomy group had higher long-term PCV and BW.Conclusions and relevanceUreterotomy demonstrated favorable outcomes for the management of feline benign ureteral obstruction, including the lowest rate of revision surgery. Improvements in PCV and BW were most pronounced in this group. In addition, surgical and hospitalization durations were comparable to those of SUB. In this single-center, single-surgeon cohort, these findings support ureterotomy as a viable and durable surgical option in appropriately selected cases, while recognizing that the results may not be generalizable to all clinical settings.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41721253/